Daiken Medical Co (JP:7775) has released an update.
Daiken Medical Co. reported a modest increase in profits for the first half of 2024, with operating profit rising by 12.3% compared to the same period last year. The company’s net sales reached ¥4,914 million, reflecting a slight growth of 1.9%. Investors may find the forecast promising as Daiken anticipates continued growth in profits and sales for the full fiscal year.
For further insights into JP:7775 stock, check out TipRanks’ Stock Analysis page.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
